Former Insys sales exec to shell out $9.5M in opioid spray kickback scheme

Insys’ former VP of sales has settled and turned state's evidence in an Arizona kickback suit alleging an executive-driven scheme to buy scripts for the company’s powerful opioid spray, Subsys. Alec Burkaloff, who pleaded guilty in a Boston courthouse in November on federal racketeering charges, agreed Wednesday to forfeit $9.5 million and admit his role in a plan to induce physicians to write scripts for the company’s under-the-tongue fentanyl spray as part of a paid speaker program he personally managed. “Individuals like Alec Burkaloff used unlawful business practices to earn millions of dollars and to fan the flames of opioid addiction," said Arizona Attorney General Mark Brnovich in a release. "This ‘profits-over-patients’ attitude has had a devastating impact on individuals and families throughout this state.”